Studies have shown that the mutation of Type 2 collagen leads to the skeletal disorder, chondrodysplasia. This disorder has received minimal attention in professional literature to date compared to other collagen mutation diseases like osteogenesis imperfecta and lathyrism, however, exploring will provide much insight and prove to be quite beneficial for other disorders that may arise from this mutation. To find the answers to underlying questions about why Type 2 collagen is the target rather than Type 1, to assess whether genetic factors are involved, as well as to investigate any preventative measures that can be taken to reduce the likelihood of developing chondrodysplasia, an orthopaedic doctor was interviewed. The complete deductions, from an expert in the field, will be presented.